Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Update - April 2012

The Scottish Medicines Consortium (SMC) has issued its monthly advice on new medicines.

Fampridine (Fampyra®) has been rejected for use to improve walking in adult patients with multiple sclerosis with walking disability. The manufacturer failed to make a submission. The manufacturer already recommends that use is restricted to prescription and supervision by physicians experienced in the management of multiple sclerosis.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - April 2012' on Email Share 'SMC Update - April 2012' on Delicious Share 'SMC Update - April 2012' on Digg Share 'SMC Update - April 2012' on Facebook Share 'SMC Update - April 2012' on reddit Share 'SMC Update - April 2012' on StumbleUpon Share 'SMC Update - April 2012' on Twitter

atomic-wealth

No Comments to “SMC Update - April 2012”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.

atomic-wealth
fond-illness
summer